Showing results (271-280 of 10,969) with videos related to
Sort By:
Pageof 1,097
Annals of Internal Medicine|July 3, 2023
In moderately to severely active UC, etrasimod increased remission at 12 and 52 wk but increased adverse eventsReem Al-Jabri, Waqqas AfifAnnals of Internal Medicine|July 3, 2023
In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 moMichelle D Kelsey, L Kristin NewbyAnnals of Internal Medicine|July 3, 2023
In type 1 diabetes, weekly basal insulin Fc was noninferior to daily insulin degludec for HbA1c at 26 wkMichael J Lockhart, Sean F DinneenAnnals of Internal Medicine|June 26, 2023
Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness StudyFaizan Khan, Doug Coyle, Kednapa Thavorn, et al.Annals of Internal Medicine|March 18, 2003
Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trialsJustin A Ezekowitz, Paul W Armstrong, Finlay A McAlisterAnnals of Internal Medicine|March 18, 2003
The relative safety of ephedra compared with other herbal productsStephen Bent, Thomas N Tiedt, Michelle C Odden, et al.Annals of Internal Medicine|March 18, 2003
Support for physician deception of insurance companies among a sample of Philadelphia residentsG Caleb Alexander, Rachel M Werner, Angela Fagerlin, et al.Annals of Internal Medicine|March 18, 2003
Evaluation of 21st-century risks of smallpox vaccination and policy optionsJ Michael Lane, Joel GoldsteinAnnals of Internal Medicine|October 1, 1975
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disordersM Lutzner, R Edelson, P Schein, et al.Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.Pageof 1,097